Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy
暂无分享,去创建一个
R. Touyz | N. Jamieson | A. McConnachie | A. Montezano | K. Mangion | Rheure Alves-Lopes | K. Neves | A. Morrow | R. Sykes | J. McAbney | C. Berry | Alasdair McIntosh | A. Kamdar | I. Caputo | H. Leslie | Assya Legrini | Colin S Wood | Kirsty Fallon | Richard McFarlane | C. Wood | Rhéure Alves-Lopes | Anna Kamdar
[1] Christopher J. L. Murray,et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. , 2022, JAMA.
[2] P. Macfarlane,et al. A multisystem, cardio-renal investigation of post-COVID-19 illness , 2022, Nature medicine.
[3] Ying Sun,et al. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research , 2022, Stem Cell Reports.
[4] A. Gasbarrini,et al. Impaired Endothelial Function in Convalescent Phase of COVID-19: A 3 Month Follow Up Observational Prospective Study , 2022, Journal of clinical medicine.
[5] C. Tsioufis,et al. Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study , 2022, Vascular Pharmacology.
[6] M. Radisic,et al. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies , 2022, eBioMedicine.
[7] L. Poon,et al. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4 , 2022, Stem Cell Reports.
[8] M. Aepfelbacher,et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme , 2022, European heart journal.
[9] M. Lederman,et al. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis , 2021, Microbiology spectrum.
[10] Y. Nishijima,et al. Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2 , 2021, Cardiovascular research.
[11] H. Jha,et al. Repurposing of gastric cancer drugs against COVID-19 , 2021, Computers in Biology and Medicine.
[12] T. Renné,et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome , 2021, Journal of Thrombosis and Haemostasis.
[13] E. Poveda,et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study , 2021, Scientific Reports.
[14] J. Chase,et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic , 2021, Annals of Intensive Care.
[15] Robert A. Campbell,et al. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction , 2021, JCI insight.
[16] P. Fadel,et al. Blunted peripheral but not cerebral vasodilator function in young otherwise healthy adults with persistent symptoms following COVID-19 , 2021, American journal of physiology. Heart and circulatory physiology.
[17] C. Dieterich,et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants , 2021, Basic Research in Cardiology.
[18] H. Sethi,et al. Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma , 2021, Clinical ophthalmology.
[19] M. Maniscalco,et al. Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation , 2021, Biomedicines.
[20] Kevin N. Heath,et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study , 2021, BMJ.
[21] W. Kuebler,et al. In vitro screening identifies TRPV4 as target for endothelial barrier stabilization in COVID‐19 , 2021, The FASEB Journal.
[22] A. Malhotra,et al. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 , 2021, Circulation research.
[23] J. Haas,et al. Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells , 2021, Circulation.
[24] P. Libby,et al. COVID-19 is, in the end, an endothelial disease , 2020, European heart journal.
[25] P. Macfarlane,et al. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study , 2020, Cardiovascular research.
[26] L. Calò,et al. Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID‐19 , 2020, Alimentary pharmacology & therapeutics.
[27] P. Davis,et al. Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients , 2020, Pharmacological Research.
[28] G. Karimi,et al. Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) , 2020, Pharmacological Research.
[29] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[30] R. Touyz,et al. Crosstalk Between Vascular Redox and Calcium Signaling in Hypertension Involves TRPM2 (Transient Receptor Potential Melastatin 2) Cation Channel. , 2019, Hypertension.
[31] P. Karki,et al. Rho and reactive oxygen species at crossroads of endothelial permeability and inflammation. , 2019, Antioxidants & redox signaling.
[32] C. Berry,et al. Systemic microvascular dysfunction in microvascular and vasospastic angina , 2018, European heart journal.
[33] R. Touyz,et al. Vascular smooth muscle contraction in hypertension , 2018, Cardiovascular research.
[34] S. Boland,et al. Rho kinase inhibitors: a patent review (2014 – 2016) , 2017, Expert opinion on therapeutic patents.
[35] C. Solomon,et al. The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review , 2016, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.
[36] H. Shimokawa,et al. RhoA/Rho-Kinase in the Cardiovascular System. , 2016, Circulation research.
[37] W. Gasper,et al. Ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery in clinical research. , 2014, Journal of visualized experiments : JoVE.
[38] P. Lograsso,et al. Rho kinase inhibitors: a patent review (2012 – 2013) , 2014, Expert opinion on therapeutic patents.
[39] Yongbo Zhang,et al. Rho kinase: A new target for treatment of cerebral ischemia/reperfusion injury , 2013, Neural regeneration research.
[40] B. M. Saraiva-Romanholo,et al. Rho-kinase inhibition attenuates airway responsiveness, inflammation, matrix remodeling, and oxidative stress activation induced by chronic inflammation. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[41] A. D'Angelo,et al. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications. , 2010, Journal of nephrology.
[42] R. Shenkar,et al. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity , 2010, The Journal of experimental medicine.
[43] V. Videm,et al. Soluble ICAM‐1 and VCAM‐1 as Markers of Endothelial Activation , 2008, Scandinavian journal of immunology.
[44] F Verrecchia,et al. [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.
[45] Julie H. Campbell,et al. Rho and vascular disease. , 2005, Atherosclerosis.
[46] A. Takeshita,et al. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. , 2004, Journal of molecular and cellular cardiology.
[47] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[48] S. Bolz,et al. Nitric Oxide‐Induced Decrease in Calcium Sensitivity of Resistance Arteries Is Attributable to Activation of the Myosin Light Chain Phosphatase and Antagonized by the RhoA/Rho Kinase Pathway , 2003, Circulation.
[49] K. Kaibuchi,et al. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. , 2000, Circulation research.
[50] A. Bloom. The biosynthesis of factor VIII. , 1979, Clinics in haematology.